US equities |
NVDA $238.90 ▲+2.12% SPCX $171.09 ▲+7.63% MU $1,063.96 ▼-1.02% TSLA $378.73 ▲+2.20% WBD $30.95 ▲+0.03% MSFT $525.18 ▲+1.48% AAPL $332.89 ▼-0.24% META $741.90 ▲+1.90%
FinancialContent

Cybin Inc. Common Shares (NY:CYBN)

8.280 UNCHANGED
Last Price Updated: 8:00 PM EST, Jan 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cybin Inc. Common Shares

< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
41 42 Next >
Psychedelic Stock Gainers And Losers From January 10, 2023 ↗
 
Via Benzinga
News headline image
Where Are Psychedelics Headed In 2023? These Two Heavy Hitters Share Their Plans ↗
It’s the beginning of 2023 and psychedelics companies are updating the public on their developmental and clinical progress as well as their selected milestones for the year. 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From January 9, 2023 ↗
 
Via Benzinga
PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Releases Status Update on Clinical Development Programs
Via Investor Brand Network
ATAI Life Sciences, Cybin Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
Psychedelic Stock Gainers And Losers From January 5, 2023 ↗
 
Via Benzinga
Seelos Therapeutics, Cybin Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Cybin Outlines Upcoming Priorities and Milestones for its Clinical Development Programs
From Cybin Inc.
Via Business Wire
News headline image
Psychedelic Stock Gainers And Losers From January 3, 2023 ↗
 
Via Benzinga
News headline image
What Happened With Psychedelics In The Last Year? 11 Key News Items, The Sector's Performance & Takeaways ↗
What a year for psychedelics! 
Via Benzinga
Psychedelic Stock Gainers And Losers From January 2, 2023 ↗
 
Via Benzinga
Psychedelic Stock Gainers And Losers From December 29, 2022 ↗
 
Via Benzinga
Psychedelic Stock Gainers And Losers From December 28, 2022 ↗
 
Via Benzinga
Psychedelic Stock Gainers And Losers From December 27, 2022 ↗
 
Via Benzinga
Psychedelic Stock Gainers And Losers From December 26, 2022 ↗
 
Via Benzinga
News headline image
6 Largest Psychedelic Drug Stocks Were -20% In December ↗
The Psychedelic Drug Stocks Index, which tracks the six largest psychedelic stocks researching the treatment of mental illnesses based on the use of one or more psychedelic substances, continued to... 
Via Talk Markets
News headline image
Psychedelic Stock Gainers And Losers From December 30, 2022 ↗
 
Via Benzinga
News headline image
Largest Psychedelic Stocks -7.6% This Week; Now -21.7% This Month ↗
Highlighting the performance of the six stocks in our Psychedelic Drug Stocks Index, which are researching the treatment of mental illnesses using 10 different psychedelic substances. 
Via Talk Markets
Psychedelic Stock Gainers And Losers From December 23, 2022 ↗
 
Via Benzinga
Cybin, ATAI Life Sciences Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
Psychedelic Stock Gainers And Losers From December 21, 2022 ↗
 
Via Benzinga
GH Research, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
Psychedelic Stock Gainers And Losers From December 19, 2022 ↗
 
Via Benzinga
Psychedelic Stock Gainers And Losers From December 14, 2022 ↗
 
Via Benzinga
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) CEO Highlights 2022 as ‘Momentous Year’
Via Investor Brand Network
Topics Intellectual Property
News headline image
Cybin Highlights 2022 Accomplishments and Milestones
From Cybin Inc.
Via Business Wire
News headline image
Major Psychedelic Drug Stocks Down Another 7% This Week; Now Down 54% YTD ↗
The 6 largest psychedelic stocks that research the treatment of a variety of mental illnesses based on the use of 10 different psychedelic substances are down again this week. 
Via Talk Markets
Seelos Therapeutics, Mind Medicine Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 16, 2022 ↗
 
Via Benzinga
News headline image
Seelos Therapeutics, Cybin Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
41 42 Next >